TY - JOUR
T1 - Improving Smoking Cessation Outcomes Through Tailored-Risk Patient Messages at a University Hospital Tobacco Cessation Service
AU - Gonzales, David
AU - Bjornson, Wendy G.
AU - Markin, Catherine J.
AU - Coleman, Trisha M.
AU - Favela, Frances
AU - Clemons, Noal
AU - Koudelka, Caroline
AU - Lapidus, Jodi A.
N1 - Publisher Copyright:
© 2020 The Authors
PY - 2020/5
Y1 - 2020/5
N2 - Background: Postdischarge follow-up is a critical step for increasing effectiveness of hospital smoking cessation treatment. A quality improvement project was undertaken at an academic medical center tobacco cessation consult service to evaluate whether a tailored message (TM) linking immediate risks of continued smoking—particularly carbon monoxide exposure—to hospital recovery would stimulate more patient interest in the hospital's cessation treatment, including agreement to postdischarge follow-up, compared to patients receiving the usual treatment protocol with a standard message (SM) regarding more general health benefits of abstinence. Methods: Data from 697 smokers ordered/referred for smoking cessation treatment in 2013 who received either the SM (January–April; n = 323) or the TM (April–November; n =374) were analyzed. Results: Multivariate regression analysis showed that the TM was associated with significantly greater agreement for follow-up (odds ratio [OR] = 10.83, 95% confidence interval [CI] = 3.66–32.04, p < 0.0001) than the SM. Those patients who received the TM were more willing to try to remain abstinent postdischarge (willingness score = 10, p = 0.0052) and engaged in longer consults (consult time > 10 minutes, p = 0.0075) than SM patients. TM patients also self-reported a higher continuous abstinence rate (OR = 2.07, 95% CI = 1.17–3.66, p = 0.0130] at follow-up than SM. Conclusion: Linking risks of continued smoking, particularly carbon monoxide exposure, to hospital patients’ immediate recovery following discharge in a treatment protocol resulted in longer consult times and increased agreement to follow-up compared to the usual protocol message. The TM was integrated into the hospital tobacco cessation intervention as standard of care.
AB - Background: Postdischarge follow-up is a critical step for increasing effectiveness of hospital smoking cessation treatment. A quality improvement project was undertaken at an academic medical center tobacco cessation consult service to evaluate whether a tailored message (TM) linking immediate risks of continued smoking—particularly carbon monoxide exposure—to hospital recovery would stimulate more patient interest in the hospital's cessation treatment, including agreement to postdischarge follow-up, compared to patients receiving the usual treatment protocol with a standard message (SM) regarding more general health benefits of abstinence. Methods: Data from 697 smokers ordered/referred for smoking cessation treatment in 2013 who received either the SM (January–April; n = 323) or the TM (April–November; n =374) were analyzed. Results: Multivariate regression analysis showed that the TM was associated with significantly greater agreement for follow-up (odds ratio [OR] = 10.83, 95% confidence interval [CI] = 3.66–32.04, p < 0.0001) than the SM. Those patients who received the TM were more willing to try to remain abstinent postdischarge (willingness score = 10, p = 0.0052) and engaged in longer consults (consult time > 10 minutes, p = 0.0075) than SM patients. TM patients also self-reported a higher continuous abstinence rate (OR = 2.07, 95% CI = 1.17–3.66, p = 0.0130] at follow-up than SM. Conclusion: Linking risks of continued smoking, particularly carbon monoxide exposure, to hospital patients’ immediate recovery following discharge in a treatment protocol resulted in longer consult times and increased agreement to follow-up compared to the usual protocol message. The TM was integrated into the hospital tobacco cessation intervention as standard of care.
UR - http://www.scopus.com/inward/record.url?scp=85082809298&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85082809298&partnerID=8YFLogxK
U2 - 10.1016/j.jcjq.2020.02.003
DO - 10.1016/j.jcjq.2020.02.003
M3 - Article
C2 - 32362354
AN - SCOPUS:85082809298
SN - 1553-7250
VL - 46
SP - 250
EP - 260
JO - Joint Commission Journal on Quality and Patient Safety
JF - Joint Commission Journal on Quality and Patient Safety
IS - 5
ER -